Galapagos expands chemistry service via Indian firms

2 July 2006

Mechelen, Belgium-based Galapagos NV, a genomics-based drug discovery company, says that its service division, BioFocus DPI, has signed collaborations with Indus Biosciences, a subsidiary of CiVentiChem in Hyderabad, and ProCitius, a division of Sanmar Speciality Chemicals in Chennai, both Indian providers of integrated chemistry services to life sciences companies. Both firms will carry out chemistry services for the BioFocus DPI Discovery Products division, with an option to provide support for client projects conducted by the BioFocus DPI Medicinal Chemistry division.

India offers chemistry capabilities with a large resource pool of qualified chemists, says Galapagos, adding that many pharmaceutical and biotechnology companies either have established their own facilities in India, or outsourced part of their chemistry to India-based contract research organizations. This outsourcing enables BioFocus DPI and its partners to benefit from the excellent cost-effective chemistry services available on the Indian sub-continent, while also enabling its clients to outsource work into Indus BioSciences and Sanmar under the management of BioFocus DPI scientists, the Belgian firm states.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight